Acacia Research - ACTG Stock Forecast, Price & News

0 analysts have issued twelve-month price targets for Acacia Research's stock. Their ACTG share price forecasts range from $7.00 to $7.00. On average, they expect the company's stock price to reach $7.00 in the next year. This suggests a possible upside of 66.7% from the stock's current price.
View analysts price targets for ACTG or view top-rated stocks among Wall Street analysts.

Acacia Research's stock was trading at $4.21 at the beginning of the year. Since then, ACTG shares have decreased by 0.2% and is now trading at $4.20.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our ACTG earnings forecast.

Acacia Research Co. (NASDAQ:ACTG) announced its quarterly earnings data on Sunday, August, 15th. The business services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.05 by $0.01. The business services provider earned $17.40 million during the quarter. Acacia Research had a negative trailing twelve-month return on equity of 6.57% and a negative net margin of 211.18%.

ETFs with the largest weight of Acacia Research (NASDAQ:ACTG) stock in their portfolio include Formidable ETF (FORH) and First Trust Dow Jones Select Microcap Index Fund (FDM).Dimensional US Small Cap Value ETF (DFSV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Acacia Research investors own include Trevena (TRVN), Advanced Micro Devices (AMD), Ampio Pharmaceuticals (AMPE), Coeur Mining (CDE), Extreme Networks (EXTR), OPKO Health (OPK), Palatin Technologies (PTN), Rigel Pharmaceuticals (RIGL), Arrowhead Pharmaceuticals (ARWR) and Catalyst Pharmaceuticals (CPRX).

Acacia Research trades on the NASDAQ under the ticker symbol "ACTG."

Acacia Research's stock is owned by a variety of institutional and retail investors. Top institutional investors include Starboard Value LP (13.05%), ArrowMark Colorado Holdings LLC (5.21%), Formidable Asset Management LLC (4.42%), Renaissance Technologies LLC (4.25%), Dimensional Fund Advisors LP (3.30%) and Pacific Ridge Capital Partners LLC (2.93%). Insiders that own company stock include Jason W Soncini, Marc W Booth, Marc W Booth, Maureen Oconnell and Richard Jay Rosenstein.
View institutional ownership trends.

Shares of ACTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ACTG stock can currently be purchased for approximately $4.20.

Acacia Research (NASDAQ:ACTG) has a market capitalization of $160.90 million and generates $59.22 million in revenue each year. The business services provider earns $149.20 million in net income (profit) each year or ($3.53) on an earnings per share basis.

Acacia Research's mailing address is 4 PARK PLAZA SUITE 550, IRVINE CA, 92614. The official website for the company is www.acaciaresearch.com. The business services provider can be reached via phone at (332) 236-8500, via email at rob@fnkir.com, or via fax at 949-480-8301.